| Literature DB >> 29043697 |
Bashir M Ayad1, Gerhard Van der Horst1, Stefan S Du Plessis2.
Abstract
Variation in the ejaculatory abstinence period suggested by different guidance bodies have resulted in a growing concern among researchers and clinicians over what the precise period of ejaculatory abstinence ought to be for an optimal semen sample. Several studies have thus been undertaken to examine the association between the length of sexual abstinence and semen characteristics. Not all studies, however, have arrived at the same conclusions. This study aims to review all existing literature published during the past few decades pertaining to the influence of ejaculatory abstinence on semen quality. For the purpose of this systematic review, all data related to sexual abstinence duration and seminal parameters were re-analysed to homogenize the current data. Thorough PubMed, MEDLINE and Google Scholar, a literature search was conducted using the keywords "sexual abstinence", "ejaculatory abstinence", "semen", "spermatozoa", "semen analysis", "sperm parameters", "motility", "reactive oxygen species (ROS)" and "DNA fragmentation". After carefully reviewing all the literature, 30 relevant papers, both written in English and published between January 1979 and December 2016, were included in this review. The weight of the evidence suggests that the decline in semen volume and sperm concentration with shorter abstinence periods is accompanied by a substantial improvement in sperm motility characteristics, especially progressive motility and velocity. Nevertheless, available data are insufficient to support definitive conclusions regarding the influence of the ejaculatory abstinence period on advanced semen parameters (ROS, DNA fragmentation and seminal plasma antioxidant capacity) and pregnancy rates. In conclusion, taking all data into account, shortening of the abstinence period may be beneficial to sperm quality. Furthermore, we recommend that the current guidelines regarding the prescribed abstinence period should be revisited. Copyright© by Royan Institute. All rights reserved.Entities:
Keywords: DNA Fragmentation; Semen Analysis; Sexual Abstinence; Sperm Motility; Spermatozoa
Year: 2017 PMID: 29043697 PMCID: PMC5641453 DOI: 10.22074/ijfs.2018.5192
Source DB: PubMed Journal: Int J Fertil Steril ISSN: 2008-0778
Abstinence periods and semen characteristics
| Type of study | Abstinence periods | Subjects | Number of subjects/samples | Volume (mL) | Concentration (106/mL) | TSC (106/ejaculate) | TMS (106/ejaculate) | Motility (%) | Progressive motility (%) | Viability (%) | Normal morphology (%) | DNA fragmentation (%) | ROS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prospective | 4 hours and 3-5 days | Volunteers | 11 | ↑ | −− | ↑ | −− | ↓ | ↓ | −− | −− | −− | −− |
| Prospective | 3 hours and 96 hours | Normozoospermic | 21 | −− | −− | −− | −− | −− | −− | −− | −− | ↔ | −− |
| Prospective | 40 minutes and 2-7 days | Oligozoospermic | 73 | ↑ | ↑ | −− | −− | −− | ↓ | −− | ↓ | −− | −− |
| Prospective | 2 hours and 3-4days | Healthy | 3 | ↑ | ↑ | ↑ | ↔ | ↔ | ↔ | ↔ | −− | ↓ | ↔ |
| Prospective | 1, 2, 3, 4, 5 and 10 days | Volunteers | 10 | ↑ | ↑ | ↑ | −− | −− | −− | ↔ | ↑ | −− | −− |
| Prospective | 1, 3, 5, and 8 days | Volunteers | 11 | ↑ | ↑ | −− | −− | ↔ | −− | ↔ | ↔ | ↔ | −− |
| Prospective | 1, 2, 5, 7, 9 and 11 days | Normozoospermic | 7 | ↑ | ↑ | ↑ | ↑ | ↔ | −− | ↓ | −− | ↑ | ↔ |
| Prospective | 1, 2, 3, 4, 5, 6 and 7 days | Normal | 36 | ↑ ↑ | ↑ | ↑ | −− | −− | −− | −− | −− | −− | −− |
| Retrospective | ≤1, 2, 3, 4, 5, 6 and 7 days | Suspected infertile | 1801 | ↑ | −− | −− | −− | ↔ | −− | ↔ | ↔ | −− | −− |
| Prospective | 8 hours and 3 days | Volunteers | 7 | ↑ | ↔ | ↑ | −− | −− | −− | −− | ↔ | −− | −− |
| Prospective | 12 hours and 7 days | Volunteers | 10 | ↑ | ↑ | ↑ | −− | ↓ | −− | −− | ↔ | −− | −− |
| Prospective | 2-4, 5-7 and ˃7 days | Healthy men | 195 | ↑ | ↔ | −− | −− | −− | −− | −− | −− | −− | −− |
| Prospective | 2, 4, 7, 10, 15 and 18 days | Volunteers | 6 | ↑ | ↑ | ↑ | −− | ↔ | −− | −− | ↔ | −− | −− |
| Prospective | ˂4, 4-6 and ˃6 days | Healthy | 27 | ↑ | ↑ | ↑ | ↔ | −− | −− | −− | ↔ | −− | −− |
| Prospective | 2-3 and 4-7 days | Non-azoospermic | 422 | ↑ | ↑ | ↑ | ↑ | ↓ | ↓ | −− | ↓ | −− | −− |
| Retrospective | 1, 2, 3, 4, 5, 6, 7, 8-10 and 11-14 days | Oligozoospermic | 3506samples | ↑ | ↑ | ↑ | ↑ | ↓ | −− | −− | ↓ | −− | −− |
| Retrospective | 1, 2, 3, 4, 5, 6, 7, 8-10 and 11-14 days | Normozoospermic | 5983 samples | ↑ | ↑ | ↑ | ↑ | ↓ | −− | −− | ↔ | −− | −− |
| Prospective | 2, 3, 4 and 5 days | Fertile | 500 | ↑ | ↑ | −− | −− | −− | ↓ | −− | ↔ | −− | −− |
| Retrospective | ≤2 and 3-7 days | Undergoing IUI | 372 | ↑ | ↑ | −− | ↑ | ↓ | −− | ↓ | −− | −− | −− |
| Prospective | 1 and 4 days | Undergoing ICSI | 40 | ↑ | −− | −− | −− | ↔ | −− | −− | −− | ↑ | −− |
| Prospective | 18-30 hours and 3-5 days | Healthy | 57 | ↑ | ↑ | −− | ↔ | ↔ | −− | −− | ↑ | ↑ | −− |
| Prospective | 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 days | Normozoospermic | 100 samples | ↑ | ↑ | ↑ | ↑ | ↓ | −− | ↔ | ↔ | −− | −− |
| Prospective | 1 and 4 days | Planning IUI | 40 | ↑ | ↑ | ↑ | −− | ↔ | −− | −− | ↔ | −− | −− |
| Retrospective | 2-3, 4-5 and 6-7 days | Attending Infertility Unit | 730 | ↑ | −− | ↑ | −− | −− | ↓ | ↓ | ↔ | −− | −− |
| Prospective | 1 and 3-4 days | Healthy | 6 | ↑ | ↑ | ↑ | −− | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ |
| Prospective | 3, 6 and 10 days | Normozoospermic | 7 | ↔ | ↑ | ↑ | ↔ | −− | ↓ | ↔ | ↔ | −− | −− |
| Prospective | 3, 6 and 10 days | Asthenozoospermic | 7 | ↔ | ↑ | ↑ | ↔ | −− | ↔ | ↔ | ↔ | −− | −− |
| Retrospective | ≤3, 4-10 and ˃10 days | Undergoing IUI | 929 | −− | ↑ | −− | ↑ | −− | ↔ | −− | −− | −− | −− |
| Prospective | 4 and 14 days | Nonobstructive azoospermic | 50 | −− | ↑ | ↑ | ↑ | ↔ | −− | −− | −− | −− | −− |
| Prospective | 1, 2, 4, 7, 10 and 14 days | Healthy | 4 | −− | −− | ↑ | ↑ | ↔ | ↔ | ↔ | ↔ | −− | −− |
| Prospective | 1 and 3-4 days | With high DNAfragmentation levels | 35 | −− | −− | −− | −− | −− | −− | −− | −− | ↑ | −− |
| Prospective | 1-10 days | Healthy | 36 samples | −− | −− | −− | −− | −− | −− | −− | −− | −− | ↔ |
TSC; Total sperm count/ejaculate, TMS; Total motile sperm/ejaculate, ROS; Reactive oxygen species, ICSI; Intracytoplasmic sperm injection, IUI; Intrauterine insemination, ↑; Increase significantly with increasing abstinence period (P≤0.05), ↓; Decrease significantly with increasing abstinence period (P≤0.05), ↔; Not significantly different, and --; Not investigated.
The overall mean values of basic semen parameters in relation to different abstinence periods calculated from values reported in relevant studies referred to in Table 1
| Semen parameter | Day | ||||
|---|---|---|---|---|---|
| ≤1 | 2-3 | 4 -5 | 6-7 | ˃7 | |
| Semen volume (mL) | 2.198 | 2.72 | 3.251 | 3.773 | 4.229 |
| n=15 | n=13 | n=18 | n=13 | n=14 | |
| Concentration (106/mL) | 54.363 | 52.038 | 66.849 | 64.623 | 70.474 |
| n=16 | n=11 | n=16 | n=11 | n=13 | |
| Total sperm count (106/ejaculate) | 99.911 | 114.306 | 172.591 | 225.792 | 288.642 |
| n=9 | n=9 | n=10 | n=10 | n=12 | |
| Total motile sperm (106/ejaculate) | 36.56 | 49.618 | 81.114 | 78.517 | 94.612 |
| n=8 | n= 8 | n=9 | n=8 | n=9 | |
| Motility (%) | 56.03 | 44.813 | 52.044 | 41.277 | 43.325 |
| n=15 | n=11 | n=15 | n=12 | n=13 | |
| Progressive motility (%) | 57.083n=6 | 54.533n=3 | 53.887 | 49.15 | - |
| n=6 | n=2 | - | |||
| Viability (%) | 66.29 | 72.37 | 73.622 | 68.4 | 66.41 |
| n=4 | n=5 | n=5 | n=5 | n=6 | |
| Normal morphology (%) | 8.453 | 9.644 | 10.16 | 8.45 | 8.590 |
| n=1 | n=14 | n=15 | n=14 | n=13 | |
The average reported in each study contributed equally to the overall mean. Only studies reporting absolute values were included. All studies were included in the calculations (e.g. normozoospermic, oligozoospermic, volunteers, patients, etc.).